Search Results - "Solza, Cristiana"
-
1
Myeloproliferative Neoplasm Symptom Assessment Form - Total Symptom Score (MPN-SAF TSS) questionnaire: translation, cultural adaptation and validation to Brazilian Portuguese
Published in Hematology, Transfusion and Cell Therapy (01-07-2022)“…Constitutional symptoms and thrombohemorrhagic events are common in patients with myeloproliferative neoplasms (MPNs). Hence, the treatment's primary goal is…”
Get full text
Journal Article -
2
Treatment outcomes in classic Hodgkin lymphoma: 5-year update from the Brazilian Hodgkin Lymphoma Registry
Published in EJHaem (01-11-2023)“…In this updated analysis, we present data on patients diagnosed up to 2018, with a median follow-up of 5 years. [...]this study highlights the need to improve…”
Get full text
Journal Article -
3
Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52 bp deletion and the ASXL1 p.R693X mutation
Published in Stem cell research (01-10-2017)“…Peripheral blood sample was donated by a 61 years old female patient diagnosed with acute myeloid leukemia secondary to a primary myelofibrosis harboring the…”
Get full text
Journal Article -
4
Familial Myelodysplastic/Acute Leukemia Syndromes-Myeloid Neoplasms with Germline Predisposition
Published in Frontiers in oncology (12-09-2017)“…Although most cases of myeloid neoplasms are sporadic, a small subset has been associated with germline mutations. The 2016 revision of the World Health…”
Get full text
Journal Article -
5
Characterization of a human induced Pluripotent Stem (iPS) cell line (INCABRi002-A) derived from a primary myelofibrosis patient harboring the 5-bp insertion in CALR and the p.W146X mutation in TP53
Published in Stem cell research (01-12-2018)“…Primary myelofibrosis (PMF) is a hematological malignancy characterized by activation of the JAK/STAT pathway and risk of leukemic transformation. In this…”
Get full text
Journal Article -
6
P018: Treatment outcomes in classical Hodgkin lymphoma (HL): 5‐year update report from the Brazilian Prospective Registry
Published in HemaSphere (03-10-2022)Get full text
Journal Article -
7
-
8
Genetic Alterations in Essential Thrombocythemia Progression to Acute Myeloid Leukemia: A Case Series and Review of the Literature
Published in Frontiers in oncology (19-02-2018)“…The genetic events associated with transformation of myeloproliferative neoplasms (MPNs) to secondary acute myeloid leukemia (sAML), particularly in the…”
Get full text
Journal Article -
9
-
10
A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients
Published in Clinical infectious diseases (01-02-2000)“…To evaluate the efficacy of itraconazole capsules in prophylaxis for fungal infections in neutropenic patients, we conducted a prospective, double-blind,…”
Get full text
Journal Article -
11
Risk Factors and Attributable Mortality Associated with Superinfections in Neutropenic Patients with Cancer
Published in Clinical infectious diseases (01-04-1997)“…To identify the risk factors and attributable mortality associated with superinfections in febrile neutropenic patients with hematologic malignancies, we…”
Get full text
Journal Article -
12
Epidemiology of invasive fungal disease in haematologic patients
Published in Mycoses (01-03-2021)“…Invasive fungal disease (IFD) is frequent in patients with haematologic malignancies and in recipients of haematopoietic cell transplantation (HCT). An…”
Get full text
Journal Article -
13
External Validation of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI): Strong Calibration in the Brazilian Prospective Hodgkin Lymphoma Registry
Published in Blood (02-11-2023)“…Background: To be useful across the broadest range of patients and clinical settings, clinical prediction models should be externally validated in different…”
Get full text
Journal Article -
14
External validation and calibration of the HoLISTIC Consortium's advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the Brazilian Hodgkin lymphoma registry
Published in British journal of haematology (17-10-2024)“…The Hodgkin lymphoma International Study for Individual Care (HoLISTIC) Consortium's A-HIPI model, developed in 2022 for advanced-stage classical Hodgkin…”
Get full text
Journal Article -
15
-
16
The Scenario of Myelofibrosis in Brazil in the View of a Panel of Experts: Challenges and Proposals
Published in Blood (13-11-2019)“…Introduction: Myelofibrosis (MF) is a rare and progressive myeloproliferative neoplasm (MPN), with increased risk of death due to disease complications and…”
Get full text
Journal Article -
17
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry
Published in Annals of hematology (01-10-2023)“…The treatment of older patients with Hodgkin lymphoma (HL) remains a challenge. We sought to identify the treatment patterns and outcomes in older HL patients…”
Get full text
Journal Article -
18
Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients—An analysis from the Brazilian Hodgkin Lymphoma Registry
Published in International journal of cancer (01-03-2018)“…Socioeconomic status (SES) is a well‐known determinant of outcomes in cancer. The purpose of this study was to analyze the impact of the SES on the outcomes of…”
Get full text
Journal Article -
19
Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis?
Published in Mycoses (01-05-2019)“…Summary Background Patients treated for invasive aspergillosis may relapse during subsequent periods of immunosuppression and should receive secondary…”
Get full text
Journal Article -
20
Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection
Published in Cancer (15-07-2003)“…BACKGROUND Invasive infection by Fusarium sp. is associated with high mortality in patients with hematologic cancer. Yet to the authors' knowledge, little is…”
Get full text
Journal Article